Back to SKYE

CITADEL ADVISORS LLC → SKYE

CITADEL ADVISORS LLC SKYE Position History

Skye Bioscience, Inc. • Healthcare

Quarters held
7
Latest value
$185K
Q3 2026
Peak value
$185K
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$24K
Q1 2026$37K
Q2 2026$61K
Q2 2026$25K
Q2 2026$61K
Q2 2026$25K
Q3 2026$185K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$185K114.9K——
Q2 2026$25K35.4K——
Q2 2026$61K88.6K——
Q2 2026$25K35.4K——
Q2 2026$61K88.6K——
Q1 2026$37K59.8K——
Q1 2026$24K39.1K——

Other funds holding SKYE

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B